Both in Pharmaceuticals
Zentalis Pharmaceuticals vs PepGen
Over the past year ZNTL returned +21.9% and PEPG returned −45.3%; their daily moves had a correlation of 0.08.
ZNTL +21.9% PEPG −45.3%Growth of $1, one year, split-adjusted
| Metric | ZNTL | PEPG |
|---|---|---|
| Price | $1.76 | $2.48 |
| Market cap | $166.1M | $171.8M |
| Today | −1.40% | +0.81% |
| 1 month | −34.3% | +7.4% |
| 6 months | −58.0% | +34.4% |
| Year to date | +30.0% | −61.9% |
| 1 year | +21.9% | −45.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $174.6M | $117.2M |
| Dividend yield | — | — |
| Volatility (60d) | 71.0% | 67.8% |
| Short % of float | 9.1% | 9.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).